The Procena kvaliteta života bolesnika lečenih zbog hroničnog pankreatitisa

  • Saša Dragović Military medical Academy
  • Maja Vulović University of Kragujevac, Faculty of Medical Sciences, Department of Anatomy and Forensic Medicine, Kragujevac,
  • Dušica Stamenković Military Medical Academy, Clinic for Anaesthesiology and Intensive Care
  • Nemanja Rančić §University of Defence, Faculty of Medicine of the Military Medical Academy
  • Miroslav Mitrović Military Medical Academy, Clinic for General Surgery
  • Mihailo Bezmarević Military Medical Academy, Clinic for General Surgery
  • Milan Jovanović Military Medical Academy, Clinic for General Surgery
  • Ivan Pantić Military Medical Academy, Clinic for General Surgery
  • Zoran Rujanovski Military Medical Academy, Clinic for General Surgery
  • Sanja Lepić University of Defence, Faculty of Medicine of the Military Medical Academy
  • Boško Milev Military Medical Academy, Clinic for General Surgery
DOI: https://doi.org/10.2298/VSP201220054D
Ključne reči: lečenje lekovima, pankreatitis, hronični, kvalitet života, hirurgija, operativne procedure, ankete i upitnici

Sažetak


Uvod

 

Hronični pankreatitis (CP) izaziva zapaljenske promene u tkivu pankreasa, što rezultira nepovratnim oštećenjem tkiva. Razvijaju se bol, endokrina i egzokrina insuficijencija pankreasa, čime se smanjuje kvalitet života pacijenata. Cilj studije je da se istraži uloga hirurškog lečenja u poboljšanju kvaliteta života pacijenata sa CP.

 

Metode

 

Procena kvaliteta života 50 pacijenata kojima je dijagnostikovana CP izvršena je korišćenjem sertifikovanog upitnika Euro Quality of life-5 dimension-5 level (EuroQol-5D-5L) prevedenog na srpski jezik. Pacijenti su popunili upitnik. Pacijenti su podeljeni u dve grupe (konzervativna - CT naspram hirurške - ST), a sva poređenja su napravljena između grupa.

 

Rezultati

 

Pacijenti  u B stadijumu hroničnog pankreatitisa su podeljeni u dve grupe od 25 pacijenata. Prva grupa pacijenata sa CP lečena je konzervativno, a druga grupa hirurškim pristupom. Prosečna starost u hirurški lečenoj grupi (ST) iznosila je 48.56 ± 11.91, a u konzervativno lečenoj grupi (CT) 51.08 ± 11.61 (p = 0.452). Odnos muškaraca i žena u ST grupi bio je 18/7, a u CT grupi 22/3 (p = 0.289). Bol u ST grupi bio je prisutan kod 23 pacijenta, a u CT grupi kod 18 pacijenata (p = 0.141). Gubitak apetita u ST grupi bio je prisutan kod 7 pacijenata, a u CT grupi kod 10 pacijenata (p = 0.256). Gubitak kilograma u obe grupe bio je jednak (p = 1.000). Na osnovu EuroQol-5D-5L utvrđene su značajne razlike (p <0.001) između grupe u pokretljivosti i bolu / nelagodnosti; kod anksioznosti / depresije (p = 0.003); u samopomoći (p = 0.004); kod Uobičajene aktivnosti (p = 0.008).

 

Zaključak

 

CP značajno smanjuju kvalitet života (QoL) pacijenata koji se leče konzervativno ili hirurškim pristupom. Ova studija je pokazala da je hirurško lečenje korisnije za kvalitet života kod pacijenata sa CP nego konzervativni pristup.

 

Ključne reči: hronični pankreatitis; bol; hirurški tretman; Kvalitet života.

 

Reference

Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, et al. Evidence-based clinical practice guidelines for chronic pan-creatitis 2015. J Gastroenterol 2016; 51(2): 85‒92.

Majumder S, Chari ST. Chronic pancreatitis. Lancet 2016; 387(10031): 1957‒66.

Drewes AM, Bouwense SAW, Campbell CM, Ceyhan GO, Delhaye M, Demir IE, et al. Guidelines for the understanding and man-agement of pain in chronic pancreatitis. Pancreatology 2017; 17(5): 720‒31.

Büchler MW, Martignoni ME, Friess H, Malfertheiner P. A pro-posal for a new clinical classification of chronic pancreatitis. BMC Gastroenterol 2009; 9: 93.

Machicado JD, Chari ST, Timmons L, Tang G, Yadav D. A popu-lation-based evaluation of the natural history of chronic pan-creatitis. Pancreatology 2018; 18(1): 39‒45.

Zhao X, Cui N, Wang X, Cui Y. Surgical strategies in the treatment of chronic pancreatitis. An updated systemic review and meta-analysis of randomized controlled trials. BMC Medi-cine (Baltimore) 2017; 96(9): e6220.

Tandan M, Talukdar R, Reddy DN. Management of pancreatic calculi: An update. Gut Liver 2016; 10(6): 873‒80.

Rasch S, Nötzel B, Phillip V, Lahmer T, Schmid RM, Algül H. Management of pancreatic pseudocysts - A retrospective anal-ysis. PloS One 2017; 12(9): e0184374.

Diener MK, Hüttner FJ, Kieser M, Knebel P, Dörr-Harim C, Dis-tler M, et al. Partial pancreatoduodenectomy versus duode-num-preserving pancreatic head resection in chronic pancrea-titis: the multicentre, randomised, controlled, double-blind ChroPac trial. Lancet 2017; 390(10099): 1027‒37.

Panek-Jeziorna M, Wierzbicki J, Annabhani A, Paradowski L, Mu-lak A. Pancreatic duct stones: A report on 16 cases. Adv Clin Exp Med 2017; 26(4): 609‒13.

WHO QOL Group. Study protocol for the World Health Or-ganization project to develop a Quality of Life assessment in-strument (WHOQOL). Qual Life Res 1993; 2(2): 153‒9.

Amann ST, Yadav D, Barmada MM, O'Connell M, Kennard ED, Anderson M, et al. Physical and mental quality of life in chron-ic pancreatitis: a case-control study from the North American Pancreatitis Study 2 cohort. Pancreas 2013; 42(2): 293‒300.

Tustumi F, Costa TN, Penteado S, Bacchella T, Cecconello I. Long Term Follow-up Results of Surgical Management of Chronic Pancreatitis. Chirurgia (Bucur) 2019; 114(3): 369‒75.

Mokrowiecka A, Pinkowski D, Malecka-Panas E, Johnson CD. Clinical, emotional and social factors associated with quality of life in chronic pancreatitis. Pancreatology 2010; 10(1): 39‒46.

Olesen SS, Juel J, Nielsen AK, Frøkjær JB, Wilder-Smith OH, Drewes AM. Pain severity reduces life quality in chronic pan-creatitis: Implications for design of future outcome trials. Pancreatology 2014; 14(6): 497‒502.

De la Iglesia-Garcia D, Vallejo-Senra N, Iglesias-Garcia J, López-López A, Nieto L, Domínguez-Muñoz JE. Increased Risk of Mor-tality Associated With Pancreatic Exocrine Insufficiency in Patients With Chronic Pancreatitis. J Clin Gastroenterol. 2018;52(8):e63–e72.

Hayes JM, Ding SL. Pancreatic stone and treatment using ERCP and ESWL procedures: a case study and review. N Z Med J 2012; 125(1361): 89‒97.

Attwell AR, Patel S, Kahaleh M, Raijman IL, Yen R, Shah RJ. ERCP with per-oral pancreatoscopy-guided laser lithotripsy for calcific chronic pancreatitis: a multicenter US experience. Gastrointest Endosc 2015; 82(2): 311‒8.

Beyna T, Neuhaus H, Gerges C. Endoscopic treatment of pan-creatic duct stones under direct vision: Revolution or resigna-tion? Systematic review. Dig Endosc 2018; 30(1): 29‒37.

Gurusamy KS, Pallari E, Hawkins N, Pereira SP, Davidson BR. Management strategies for pancreatic pseudocysts. Cochrane Database Syst Rev 2016; 4(4): CD011392.

Sachdev AH, Gress FG. Celiac Plexus Block and Neurolysis: A Review. Gastrointest Endosc Clin N Am 2018; 28(4): 579‒86.

Bang JY, Sutton B, Hawes RH, Varadarajulu S. EUS-guided ce-liac ganglion radiofrequency ablation versus celiac plexus neu-rolysis for palliation of pain in pancreatic cancer: a random-ized controlled trial (with videos). Gastrointest Endosc 2019; 89: 58‒66.e3.

D'Haese JG, Cahen DL, Werner J. Current Surgical Treatment Options in Chronic Pancreatitis. Pancreapedia: Exocrine Pan-creas Knowledge Base 2016; DOI: 10.3998/panc.2016.26.

Machicado JD, Amann ST, Anderson MA, Abberbock J, Sherman S, Conwell DL, et al. Quality of Life in Chronic Pancreatitis is Determined by Constant Pain, Disability/Unemployment, Current Smoking, and Associated Co-Morbidities. Am J Gas-troenterol 2017; 112(4): 633‒42.

EuroQol Group. EQ-5D-5L – EQ-5D. Available from: http://www.euroqol.org/home.html.

Braganza JM, Lee SH, McCloy RF, McMahon MJ. Chronic pan-creatitis. Lancet 2011; 377(9772): 1184‒97.

Fitzsimmons D, Kahl S, Butturini G, van Wyk M, Bornman P, Bas-si C, et al. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26. Am J Gastroenterol 2005; 100(4): 918‒26.

Aimoto T, Uchida E, Matsushita A, Kawano Y, Mizutani S, Koba-yashi T. Long-term outcomes after Frey's procedure for chron-ic pancreatitis with an inflammatory mass of the pancreatic head, with special reference to locoregional complications. J Nippon Med Sch 2013; 80(2): 148‒54.

Tarasenko SV, Natal’skiy AA, Zaytsev OV, Sokolova SN, Bo-gomolov AY, Rakhmaev TS, et al. Assessment of quality of life of patients operated for chronic pancreatitis. Kaz Med J. 2017; 98(5): 709–13.

Hildebrand P, Duderstadt S, Jungbluth T, Roblick UJ, Bruch HP, Czymek R. Evaluation of the quality of life after surgical treatment of chronic pancreatitis. JOP 2011; 12(4): 364‒71.

Soundararajan L, Ulagendraperumal S, Prabhakaran R, Naganath-babu OL. Frey’s procedure - does it improve quality of life?: a single centre experience of long term outcome following Frey’s. Int Surg J 2020; 7(3): 733‒7.

Pezzilli R, Bini L, Fantini L. Quality of life in chronic pancrea-titis. World J Gastroenterol. 2006; 12(39): 6249–6251.

Nitesh PNB, Reddy VV, Gavini SK. Assessment of functional outcome of patients undergoing surgery for chronic pancreati-tis: A prospective study. Ann Hepatobiliary Pancreat Surg 2020; 24(2): 162‒7.

Beyer G, Habtezion A, Werner J, Lerch MM, Mayerle J. Chronic pancreatitis. Lancet 2020; 396(10249): 499‒512.

Gopalakrishnan G, Kalayarasan R, Gnanasekaran S, Pottakkat B. Frey's plus versus Frey's procedure for chronic pancreatitis: Analysis of postoperative outcomes and quality of life. Ann Hepatobiliary Pancreat Surg 2020; 24(4): 496‒502.

Objavljeno
2022/11/01
Broj časopisa
Vol. 79 Br. 09 (2022): Vojnosanitetski pregled
Rubrika
Originalni članak